V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160014547 | 160017844 | 1.78 | 66.5 | Palliative (P) | 2019-11-01 | 2019-11-22 | Bevacizumab 7.5mg/kg | 02 | N | LIPOSOMAL DOXORUBICIN | 101697477 |
| 160014557 | 160017845 | 1.64 | 47 | Curative (C) | 2021-02-12 | 2021-02-19 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 101290598 |
| 160014564 | 160017846 | 1.64 | 80 | Palliative (P) | 2019-09-20 | 2019-10-15 | Docetaxel + Gemcitabine (prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 101218089 |
| 160014566 | 160017847 | 1.46 | 118 | Palliative (P) | 2019-03-25 | 2019-04-05 | Bevacizumab 7.5mg/kg | 02 | N | DOCETAXEL + GEMCITABINE | 100288604 |
| 160014571 | 160017848 | 1.74 | 52.5 | Palliative (P) | 2020-07-12 | 2020-10-10 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100911570 |
| 160014573 | 160017849 | 1.67 | 87.4 | Palliative (P) | 2020-10-23 | 2021-04-11 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101169864 |
| 160014582 | 160017850 | 1.68 | 60.5 | null | 2018-04-12 | 2018-04-18 | Bevacizumab | 02 | null | CARBOPLATIN + PACLITAXEL | 100440572 |
| 160014583 | 160017851 | 1.44 | 160 | Palliative (P) | 2019-08-06 | 2019-08-14 | Bevacizumab 15mg/kg | 02 | N | CISPLATIN + PEMETREXED | 100308658 |
| 160014586 | 160017852 | 1.48 | 69.2 | null | 2017-10-25 | 2017-11-05 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + PACLITAXEL | 100657445 |
| 160014599 | 160017853 | 1.75 | 79.4 | null | 2020-09-08 | 2020-09-26 | Bevacizumab | 02 | null | CARBOPLATIN + GEMCITABINE | 101830852 |
| 160014601 | 160017854 | 1.51 | 81.4 | Palliative (P) | 2018-09-15 | 2018-09-28 | Bevacizumab | 02 | N | LIPOSOMAL DOXORUBICIN | 100714642 |
| 160014606 | 160017855 | 1.73 | 85.5 | Adjuvant (A) | 2017-04-22 | 2017-04-26 | Bevacizumab | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101108328 |
| 160014620 | 160017856 | 1.67 | 70.9 | null | 2019-10-26 | 2019-11-04 | Bevacizumab 7.5mg/kg | null | null | CARBOPLATIN + GEMCITABINE | 100697434 |
| 160014632 | 160017857 | 1.57 | 62.4 | null | 2018-06-12 | 2018-06-19 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 101668835 |
| 160014633 | 160017858 | 1.74 | 75.4 | null | 2021-01-14 | 2021-01-15 | Bevacizumab | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100508107 |
| 160014634 | 160017859 | 1.7 | 109.8 | Palliative (P) | 2021-02-25 | 2021-03-21 | Liposomal Doxorubicin 50mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 101617506 |
| 160014647 | 160017860 | 1.69 | 119.5 | Palliative (P) | null | 2019-07-12 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100324751 |
| 160014661 | 160017861 | 1.51 | 53.8 | Adjuvant (A) | 2019-02-09 | 2019-02-09 | Bevacizumab | 02 | N | CARBOPLATIN + PACLITAXEL | 100456004 |
| 160014662 | 160017862 | 1.44 | 109.4 | Palliative (P) | 2020-07-02 | 2020-07-16 | Bevacizumab 15mg/kg | 02 | N | PACLITAXEL | 100564755 |
| 160014664 | 160017863 | 1.67 | 90 | Palliative (P) | 2021-04-12 | 2021-04-17 | Bevacizumab | 02 | N | LIPOSOMAL DOXORUBICIN | 100957081 |
| 160014678 | 160017864 | 1.64 | 79.8 | Neo-adjuvant (N) | null | 2019-05-27 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + PACLITAXEL | 100381152 |
| 160014682 | 160017865 | 1.75 | 59.5 | null | 2017-12-10 | 2018-01-12 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101643280 |
| 160014683 | 160017866 | 1.51 | 96.7 | Palliative (P) | 2016-09-08 | 2016-09-08 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 101665060 |
| 160014689 | 160017867 | 1.79 | 77.1 | Neo-adjuvant (N) | 2019-10-03 | 2020-03-04 | Bevacizumab 7.5mg/kg | 02 | N | LIPOSOMAL DOXORUBICIN | 100753339 |
| 160014696 | 160017868 | 1.75 | 73.8 | Palliative (P) | 2020-01-01 | 2020-01-01 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100562745 |
| 160014714 | 160017869 | 1.69 | null | Palliative (P) | 2021-03-11 | 2021-03-14 | Bevacizumab | 02 | N | CARBOPLATIN + PACLITAXEL | 100255650 |
| 160014729 | 160017870 | 1.78 | 68.8 | Palliative (P) | 2019-08-26 | 2020-01-05 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN | 100174454 |
| 160014735 | 160017872 | 1.67 | 57.2 | Palliative (P) | 2016-03-16 | 2016-09-03 | PACLITAXEL | 02 | N | PACLITAXEL | 101134390 |
| 160014742 | 160017873 | 1.76 | 70.8 | null | 2019-01-24 | 2019-08-15 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101359620 |
| 160014749 | 160017874 | 1.74 | 101.45 | Palliative (P) | 2017-06-02 | 2018-06-05 | Docetaxel + Gemcitabine (prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 101504366 |
| 160014769 | 160017875 | 1.67 | 67 | Palliative (P) | 2019-03-23 | 2019-04-07 | Liposomal Doxorubicin 40mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 100426511 |
| 160014770 | 160017876 | 1.83 | 73.7 | Palliative (P) | 2019-11-01 | 2019-11-22 | Bevacizumab 7.5mg/kg | 02 | N | DOCETAXEL + GEMCITABINE | 100794280 |
| 160014780 | 160017877 | 1.7 | 51 | Curative (C) | 2016-09-24 | 2017-05-05 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 100330010 |
| 160014785 | 160017878 | 1.76 | 64.2 | null | 2018-09-27 | 2019-01-11 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + PACLITAXEL | 100694870 |
| 160014788 | 160017879 | 1.7 | 59 | Palliative (P) | 2017-02-05 | 2017-06-26 | Bevacizumab 7.5mg/kg | 2 | N | CARBOPLATIN | 101840982 |
| 160014792 | 160017880 | 1.81 | 78 | null | 2019-11-19 | 2019-11-19 | Bevacizumab 7.5mg/kg | 02 | null | DOXORUBICIN + OLARATUMAB | 100125038 |
| 160014798 | 160017881 | 1.84 | 90 | null | 2019-04-02 | 2019-05-25 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN | 101328497 |
| 160014805 | 160017882 | 1.73 | 88 | Palliative (P) | 2021-02-13 | 2021-03-03 | Bevacizumab 7.5mg/kg | 02 | N | DOXORUBICIN + OLARATUMAB | 101441226 |
| 160014816 | 160017883 | 1.8 | 59.5 | Palliative (P) | 2021-11-01 | 2021-11-10 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + GEMCITABINE | 100241575 |
| 160014818 | 160017884 | 1.81 | 93.6 | Palliative (P) | 2017-06-02 | 2017-09-01 | Bevacizumab | 02 | N | DOCETAXEL + GEMCITABINE | 100979121 |
| 160014821 | 160017885 | 1.51 | 88 | null | 2017-10-18 | 2017-10-27 | Bevacizumab 7.5mg/kg | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101055623 |
| 160014828 | 160017886 | 1.51 | 73.85 | Palliative (P) | 2012-10-10 | 2016-09-10 | CARBOPLATIN + GEMCITABINE | 2 | N | CARBOPLATIN + GEMCITABINE | 100193688 |
| 160014840 | 160017887 | 1.63 | 83.5 | Palliative (P) | 2019-10-25 | 2020-05-13 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100428462 |
| 160014841 | 160017888 | 1.74 | 69.5 | null | 2019-02-10 | 2019-02-11 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100768747 |
| 160014845 | 160017889 | 1.75 | 82 | null | 2017-07-27 | 2021-03-06 | Bevacizumab | 02 | null | LIPOSOMAL DOXORUBICIN | 100169298 |
| 160014851 | 160017890 | 1.48 | 98 | null | null | 2019-04-18 | Bevacizumab | 02 | null | CARBOPLATIN | 101703111 |
| 160014860 | 160017891 | 1.51 | 53.9 | null | 2017-08-08 | 2017-08-19 | Bevacizumab | 02 | null | CARBOPLATIN + PACLITAXEL | 101077483 |
| 160014878 | 160017892 | 1.52 | 53.3 | Disease modification (D) | 2019-05-13 | 2020-01-05 | Liposomal Doxorubicin (Caelyx) | 02 | Y | LIPOSOMAL DOXORUBICIN | 100653598 |
| 160014889 | 160017893 | 1.54 | 79.6 | Palliative (P) | 2020-07-08 | 2020-11-13 | Bevacizumab | 02 | N | DOCETAXEL + GEMCITABINE | 101311602 |
| 160014906 | 160017894 | 1.51 | 118.5 | Palliative (P) | 2020-06-11 | 2020-06-13 | Bevacizumab 7.5mg/kg | 02 | N | PACLITAXEL | 101366873 |